Stock listing

NYSE:ADCT ADC Therapeutics SA Stock

Home listing (NYSE) of ADC Therapeutics SA

Follow ADC Therapeutics SA into a list and get an email when it puts out news.

Share price · NYSE:ADCT

$1.53 USD +0.04 (+2.7%)

Close on Oct 30, 2026

Past year -67.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$1.43 – $1.54 USDOct 30, 2026
Volume
1.18M sharesOct 30, 2026
Market cap
$195.3M USDAt the close on Oct 30, 2026 · price × 127.7M shares outstanding
52-week range
$0.78 – $4.98 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$1.94M USDMedian day 1.29M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
ADC Therapeutics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:ADCT · Home$1.53 USD+0.04 (+2.7%)1,175,387$1.49$1.54$1.43$1.49Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:ADCT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.53+0.04+2.7%$1.49$1.54$1.431,175,387
$1.49-0.13-8.0%$1.67$1.70$1.49899,752
$1.62+0.03+1.9%$1.59$1.63$1.545607,765
$1.59+0.08+5.3%$1.49$1.60$1.461,250,598
$1.51+0.07+4.9%$1.45$1.54$1.431,048,540
$1.44-0.16-10.0%$1.58$1.585$1.431,045,600
$1.60+0.10+6.7%$1.50$1.62$1.479824,844
$1.50-0.02-1.3%$1.53$1.555$1.441,328,331
$1.52+0.08+5.6%$1.45$1.55$1.431,057,352
$1.44+0.04+2.9%$1.40$1.49$1.39575,619
$1.40-0.09-6.0%$1.49$1.51$1.40799,525
$1.49+0.04+2.8%$1.47$1.565$1.461,331,061
$1.45-0.25-14.7%$1.67$1.725$1.401,741,916
$1.70-0.16-8.6%$1.86$1.86$1.6253,325,278
$1.86+0.13+7.5%$1.70$1.87$1.641,593,120
$1.73+0.14+8.8%$1.58$1.83$1.563,143,187
$1.59+0.17+12.0%$1.41$1.63$1.325,552,486
$1.42+0.15+11.8%$1.25$1.44$1.2351,750,770
$1.27+0.04+3.3%$1.25$1.27$1.201,352,795
$1.23+0.10+8.8%$1.12$1.26$1.111,752,161
$1.13+0.05+4.6%$1.10$1.14$1.061,320,588
$1.08-0.14-11.5%$1.20$1.201$1.07862,274
$1.22-0.01-0.8%$1.23$1.285$1.201,111,965
$1.23-0.03-2.4%$1.27$1.29$1.20781,015
$1.26-0.01-0.8%$1.24$1.27$1.20835,119
$1.27-0.02-1.6%$1.26$1.285$1.211,076,982
$1.29-0.02-1.5%$1.305$1.31$1.241,575,647
$1.31+0.08+6.5%$1.24$1.32$1.211,972,380
$1.23+0.11+9.8%$1.13$1.25$1.121,674,295
$1.12+0.07+6.7%$1.05$1.13$1.0351,899,275
$1.05-0.01-0.9%$1.06$1.145$1.051,577,209
$1.06+0.01+1.0%$1.06$1.10$1.011,545,569
$1.05-0.04-3.7%$1.09$1.095$1.0253,316,970
$1.09-0.02-1.8%$1.12$1.12$1.031,259,823
$1.11+0.04+3.7%$1.07$1.12$1.06808,479
$1.07-0.04-3.6%$1.13$1.156$1.04989,105
$1.11-0.11-9.0%$1.21$1.24$1.07957,194
$1.22-0.08-6.2%$1.28$1.31$1.1911,709,284
$1.30-0.06-4.4%$1.33$1.35$1.27930,761
$1.36+0.04+3.0%$1.30$1.37$1.301,478,303
$1.320.000.0%$1.32$1.37$1.302,774,762
$1.32+0.08+6.5%$1.23$1.35$1.231,955,644
$1.24+0.07+6.0%$1.15$1.24$1.141,149,641
$1.17+0.03+2.6%$1.13$1.19$1.1251,251,778
$1.14+0.02+1.8%$1.11$1.17$1.072,577,910
$1.12+0.07+6.7%$1.05$1.14$1.051,403,771
$1.05+0.01+1.0%$1.04$1.075$1.011,947,239
$1.04+0.075+7.8%$0.976$1.05$0.963,927,974
$0.965-0.032-3.2%$0.99$1.00$0.951640,512
$0.997+0.037+3.8%$0.974$1.00$0.971,088,237
$0.96-0.08-7.7%$1.02$1.04$0.952,422,878
$1.04+0.01+1.0%$1.05$1.09$1.0151,900,697
$1.03-0.07-6.4%$1.05$1.08$1.033,444,158
$1.10+0.09+8.9%$0.99$1.10$0.953,732,948
$1.01-0.04-3.8%$1.02$1.04$1.001,347,088
$1.05-0.18-14.6%$1.07$1.10$0.9392,190,300
$1.23+0.05+4.2%$1.20$1.23$1.155563,556
$1.18+0.05+4.4%$1.11$1.20$1.11664,343
$1.130.000.0%$1.14$1.17$1.12569,554
$1.130.000.0%$1.08$1.17$1.08534,556
$1.13+0.06+5.6%$1.07$1.13$1.07722,735
$1.07-0.03-2.7%$1.11$1.15$1.07971,135
$1.10+0.05+4.8%$1.05$1.12$1.041,368,010
$1.050.000.0%$1.07$1.08$1.03866,391
$1.05-0.06-5.4%$1.11$1.12$1.045757,729
$1.11+0.01+0.9%$1.09$1.13$1.07887,735
Ticker
NYSE:ADCT
Asset type
Stock
Exchange
NYSE
Currency
USD

What changed lately

Calls

Replays

  • ADC Therapeutics (NYSE:ADCT) Q2 2026 Earnings Call

    Thu, Aug 13, 2026 · 8:30 AM ET

    Watch Transcript
  • ADC Therapeutics (NYSE:ADCT) Q1 2026 Earnings Call

    Mon, May 04, 2026 · 8:30 AM ET

    Watch Transcript
  • ADC Therapeutics (NYSE:ADCT) Q4 2025 Earnings Call

    Tue, Mar 10, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

All ADC Therapeutics SA news

Financings

  • Private placement of common shares and pre-funded warrants

    Oct 8, 2026

    Announced: US$86.6M · US$1.42 a share · Jefferies +2

    Dealers: Jefferies, Guggenheim Securities, Cantor

    Buyers: Bain Capital Life Sciences; Redmile; TCGX; Nantahala Capital

    Use of proceeds: Fund ZYNLONTA pipeline studies including Phase 3 trials in DLBCL and MZL, strengthen the balance sheet, working capital and general corporate purposes

    Announced Oct 8, 2026

Read by 6ix AI from the company's releases

Decks

ADC Therapeutics SA on 6ix

News releases
22 in the last 12 months · 40 in all · newest Oct 29, 2026 · oldest 2025
Calls
25 calls with a replay · 25 with a transcript · latest Aug 13, 2026
Decks
36 decks · latest Aug 13, 2026

Where ADC Therapeutics SA is listed

ListingExchangeCountryCurrency
NYSE:ADCT · Home listing · This pageNYSEUnited StatesUSD
BOATS:ADCTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about ADC Therapeutics SA.